Fundraising FoxElysia Capital
Impact investorTurin · 6 people tracked
Find your way into Elysia Capital
Each arrow is one introduction. Sign up to fill in the first one.
Ask Stephen Fahy to introduce you to Farhan Munir
You →Stephen · together at BDO LLP →Farhan
Ask Jamie Chen to introduce you to Stefano Buono
You →Jamie · together at Abeona Therapeutics →Stefano
Ask Sam Okafor to introduce you to Martina Permegian
You →Sam · together at Università degli Studi di Torino →Martina
- Viviana Lanzetti35 people can intro you
Sign up to find every way you can get introduced to Elysia Capital
- Your email: who you already know at Elysia Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Elysia Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Elysia Capital invests in sustainable projects and ideas with the potential to become significant enterprises, backing their evolution and growth. The firm frames its mission around improving the world and increasing the wellbeing of society, aiming to positively influence the lives of as many people as possible. Its outlook emphasizes progress viewed through the lens of nature and the creation of business value that benefits everyone, positioning itself as a bridge toward a new era.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website
What they invest in
from 18 of 25 portfolio companiesHealthtech ×5Biotech ×4Consumer ×4Deep Tech ×3Media & Entertainment ×3Medical Devices ×3Digital Health ×2Hardware ×2
HQs:Italy×7United States×4Switzerland×1Colombia×1
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×62 founders×23 founders×1
Investments · 25 tracked
founders shown can be your intro pathAbeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer.
BiotechDigital HealthHealthtechMedical DevicesCleveland, US
Timothy Miller(President, Chief Executive Officer and Manager)in
BoardAl Hawkins(Chairman and Manager)
Affera develops a medical technology platform for treating cardiac arrhythmias, including atrial fibrillation, using innovative ablation solutions.
HealthtechMedical DevicesNewton, US
Doron Harlev(CEO, Founder)in
Co-investorsBain Capital Life Sciences
Asia Strategic is an investment and operating group focused on South East Asia, active across education, hospitality, and business services, with interest in healthcare, retail services, and renewable energy.
Impact & Social GoodSector Agnostic
Co-investorsMACAN
D-Orbit provides space logistics infrastructure and transportation services including satellite launch deployment, on-orbit servicing, refueling, and end-of-mission disposal using its proprietary ION Satellite Carrier orbital transfer vehicle.
Deep TechLogistics & Supply ChainSpace TechItaly, IT
Luca Rossettini(Founder & Chief Executive Officer)inRenato Panesi(Founder & Chief Commercial Officer)in
Co-investorsAstor PerkinsBanca Investis — Family OfficeCDP Venture CapitalIceNineIn-Q-TelIndaco Venture Partners+12 more
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software.
HealthtechMedical Devices
Giovanni Leo(Co-Founder)Douglas Packer(Co-Founder & Key Advisor)Ugo Amaldi(Co-Founder & Key Advisor)Marina Izzo(Chief Executive Officer & Director)inAdriano Garonna(Chief Technology Officer)inOlivier Coquoz(Head of R&D)
Co-investorsCDP Venture CapitalLIFTTOCCIDENT
Elysia Productions is a film production company whose feature "A Muso Duro" was recognized at the Italian Contemporary Film Festival (ICFF) in Toronto in November 2023.
Media & Entertainment
Erbert prepares fresh, ready-to-eat meals without preservatives that heat in two minutes, targeting health-conscious consumers seeking convenient nutritious options in stores, for delivery, or at offices.
ConsumerFoodTechWellness & Fitness
GenomSys develops modular software for storing, processing and sharing genomic data based on the ISO/IEC 23092 MPEG-G standard, serving diagnostic laboratories, hospitals, research centers and biotech companies.
BiotechData & InfrastructureDigital HealthHealthtechSaaSLugano, CH
Antonio Aitoro(Chief Executive Officer)in
Co-investorsLevensohn Venture Partners
Jardines Llano Grande is a leisure and hospitality venue offering outdoor dining and relaxation spaces with affiliated restaurants and dining partners.
ConsumerLlano Grande, CO
Kither Biotech is a clinical-stage biotech company developing inhaled cell signal transduction modulators targeting the PI3Kγ signaling axis for respiratory diseases such as COPD, non-cystic fibrosis bronchiectasis, cystic fibrosis, and idiopathic pulmonary fibrosis.
BiotechHealthtech
Co-investors3B Future Health FundCDP Venture CapitalClaris VenturesItalian Angels for Growth
LIFTT is a network organization in Italy that connects investors and innovators to support the development of future-oriented competencies and entrepreneurship within the country.
Deep TechImpact & Social GoodNew MaterialsSector AgnosticSemiconductorsTurku, IT
Stefano Buono(President)
Co-investorsAlumni VenturesIAG Capital PartnersJ-VenturesSerpentine VenturesVoima Ventures
Massimo de Carlo is an art gallery that represents contemporary artists and organizes exhibitions in multiple locations including Hong Kong, London, Milano, and Paris.
Media & EntertainmentMilano, IT
Microchannel Devices manufactures printed circuit heat exchangers (PCHEs) and microchanneled thermal components using chemical etching and diffusion bonding, handling design and production in-house for extreme pressure and temperature conditions.
Advanced ManufacturingEnergyHardware
Co-investorsLIFTT
Visto is a platform that helps brands source custom video content from creators and brand enthusiasts, offering services ranging from open creative challenges to fully produced custom videos and strategic consultation on video distribution.
Creator EconomyMarketing TechMedia & Entertainment
Paolo Tenna(Founder)in
Co-investorsClub degli Investitori
BiotechGreenwhich, US
Wendy DiCicco(Ms. DiCicco is the Secretary and Treasurer of the Issuer.)inArthur Feldman(Director)Magdalene Cook(Executive Officer, Director)Campbell Murray(Director)Edward J. Benz, Jr.(Director)Thomas Needham(Director)in
Co-investorsBioAdvanceBroadview VenturesInnogest CapitalNew Leaf Venture PartnersNovartis Venture Fund
Sailogy is an online platform for booking sailing and yacht holidays, offering around 22,000 boats across worldwide destinations with options for bareboat or skippered charters.
ConsumerMarketplacesTravel & Hospitality
Co-investorsClub Italia Investimenti 2TiVenture SA
Terabee develops time-of-flight distance sensors, 3D and thermal cameras, and IoT solutions such as people-counting, occupancy, and air-quality devices, serving mobile robotics, industrial process control, smart agriculture, traffic management, and smart buildings applications.
CleantechDeep TechHardwareIoT
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Crisalide RecordsFarmalistoHookMerkaorganicoNewcleoPlanet Smart City
Exits · 1
1 IPOsAbeona TherapeuticsNASDAQ: ABEO
Portfolio news
latest coverage across their companiesAsia Strategic Holdings · asia-strategic.com · Apr 6, 2026
LIFTT · liftt.com · Nov 4, 2025
Frequently asked questions
- How many investments has Elysia Capital made?
- Elysia Capital has 25 tracked investments, 1 of which have exited.
- What sectors does Elysia Capital focus on?
- Elysia Capital focuses on Biotech, Healthtech, Impact & Social Good, Medical Devices, PropTech, Robotics, Sector Agnostic, Space Tech.
- Where is Elysia Capital located?
- Elysia Capital is headquartered in Turin, IT.
- Who does Elysia Capital co-invest with?
- Elysia Capital most often shares deals with CDP Venture Capital, LIFTT, NovaCapital, among 26 tracked co-investors.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
This page is the analysis and research library of BDC (Business Development Bank of Canada), listing studies, surveys and reports on issues affecting Canadian small and medium-sized businesses and the venture capital landscape.
Flucas Ventures is a solo GP fund led by Ashley Flucas, who simultaneously serves as COO of Summit Ventures while personally investing in 250-275+ startups and deploying over $75M through a syndicate of 2,000+ LPs in less than two years. The fund operates with true stage, sector, and geography agnosticism while democratizing access to top-tier venture deals by inviting diverse, nontraditional LPs to co-invest alongside marquee firms like Sequoia and Andreessen Horowitz.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
VU Venture Partners is a global early-stage technology venture capital fund investing across the world's largest market opportunities, operating with a large investment team and six vertical-focused practices.